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ABSTRACT 
 
 
Introduction: Cannulation of the left ventricle (LV) apex is a common surgical 
procedure for aortic valve bypass and ventricular assist device (VAD) implantation.    LV 
cannulation requires coring of the LV apex and attaching a sewing ring via suture.  
Although effective, suturing is time-consuming and apical coring can lead to bleeding 
complications or inflow occlusion. The scope of this project was to design a sutureless-
anchoring device for an apical left ventricular (ALV) cannula system.   
 
Instrumentation, equipment, and procedures: The sutureless-anchoring device was 
designed as a conical spring.  Five prototypes were fabricated with varying wire diameter 
(0.045”-0.055”), maximum cone diameter (0.85”-0.975”), and spring height (0.75”-
1.25”).  The conical springs were attached to PVC cylinders to mimic ALV cannulae.  
The prototypes were tested through 1) leak test with pressurized porcine hearts, 2) tensile 
pull test using porcine hearts and an INSTRON, and 3) quantitative assessment of device 
implantation by cardiothoracic surgeons.   
 
Results and Discussion: Leak testing determined that the prototypes created a leak-proof 
tissue-cannula interface.  The prototype with the largest cone and wire diameter 
combination was able to achieve a tensile failure force similar to that of a clinically-used 
v 
 
VAD sewing ring.  Other prototypes yielded failure forces below the VAD sewing rings.  
The quantitative assessment reported that the prototype easily penetrates the tissue and is 
quicker to implant than sewing rings.   
 
Conclusions:  This preliminary study demonstrated promise for a sutureless-anchoring 
device as part of an ALV cannula system.  A sutureless implantation method may lead to 
safer and faster LV cannulation surgeries, thus improving patient outcomes and reducing 
surgical cost.    
Recommendations: It is recommended to test springs with larger wire diameter and 
large end outer diameter combinations than those tested in this study.  It is also 
recommended to create and test multiple prototypes of each variation of spring 
dimensions. 
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I. INTRODUCTION 
   Cannulation of the left ventricle (LV) apex is a common surgical procedure for 
aortic valve bypass and ventricular assist device (VAD) implantation.    LV cannulation 
requires coring of the LV apex and attaching a sewing ring via suture.  Although 
effective, suturing is time-consuming and apical coring can lead to bleeding 
complications or inflow occlusion. 
The scope of this project was to design a sutureless-anchoring device for an apical 
left ventricular (ALV) cannula system.  The selected design for the sutureless-anchoring 
device is a conical screw attached to the cannula, which will be implanted into the heart 
using the Seldinger technique.  A small incision will be made in the apex of the heart and 
then using dilating catheters, the incision will be dilated to the appropriate size and the 
cannula will be fed over the final catheter into the apex.  The cannula will then be secured 
in place, by turning the cannula clockwise until the screw is fully embedded in the heart. 
It will then be connected to either a Dacron graft for aortic valve bypass (AVB) or a 
VAD for device implantation.  This will remove the need for sewing rings and coring of 
the heart, theoretically, reducing time of procedure and blood loss.   
There are current procedures in place for aortic stenosis treatment and VAD 
imlantation that have reduced the amount of blood loss and need for coring of the apex.  
One such method for treating patients with aortic stenosis is aortic valve replamcent via  
transcatheter valve implantation (TVI).  In TVI a balloon catheter is fed through the apex 
of the heart or the femoral artery into the aortic valve opening.  Once the catheter has 
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been fed into the aortic valve opening the balloon is inflated and a stent with a porcine 
valve is secured in the place of the original aortic valve (FIGURE 1).  It has been shown 
that, when the TVI expands the native valve, calcium deposits breakoff increasing the 
risk for cerebral embolisms and stroke [1,2].  Traditionally, patients with severe aortic 
stenosis that were considered high risk were denied treatment as aortic valve replacement 
surgery is invasive and could lead to perioperative mortality and morbidity with this 
group of patients.   However, TVI and AVB are both suitable procedures for patients that 
have severe aortic stenosis and are high risk.  Unique LVAD designs have similarly 
removed the need for apical coring, such as the Impella LD, a temporary LVAD.  
Implantation of the Impella LD is through an incision in the femoral artery; the device is 
then fed into the left ventricle through the aortic valve and remains there. The Impella 
system is only intended to provide temporary treatment and has limited flow support.  
The maximum outflow of the Impella system is 5.3 L/min, half the inflow of other 
LVAD systems [3,4].  Both of these methods eliminate the need for apical cannulation 
and coring however they still have limitations that an ALV system overcomes.  The 
proposed ALV cannula system is a permanent solution implanted into the apex of the 
heart so it does not come into contact with the aortic valve, reducing the potential for 
embolisms originating from a manipulated valve.   
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FIGURE 1- Pictures of Transapical and Transfemoral Valve Implantation Techniques 
 After an extensive literature review, it was found that there are no sutureless-
anchoring devices on the market currently.  Similar ideas of securing devices in the heart 
using a screw can be found with pacemaker leads.  One type of pacemaker lead utilizes a 
helical screw to position the lead in the heart (FIGURE 2).  The pacemaker screw is used 
for securement of the lead to the heart and emission of electrical signals for pacing.  The 
screws in this study are conical and intended purpose is solely for securement of the 
cannula system in the heart.   
 
FIGURE 2- Screw in pacemaker lead 
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 The conical screw design for the sutureless anchoring device is constrained by 
two critical features: 1) LV wall thickness (anatomical feature), and 2) cannula inflow tip 
outer diameter (device feature).  Through recommendations from experienced clinical 
professionals, as well as, dimensions found in papers it was determined the wall 
thickness at the apex of the heart ranged from 19-30mm (0.75”-1.18”) in patients with 
severe left ventricular hypotrophy [5,6].  These values were used to determine the 
lengths of screws to use for this study.  The cannula inflow tip outer diameter from 
previous studies determined that the optimum outer diameter for the cannula was 14 mm 
(0.55”).  This value was used to determine the large end outer diameter for the springs in 
this study.  The outer diameter was chosen so that it would allow clearance around the 
cannula, but not too large that would inhibit the screw from penetrating the heart.  
The sutureless-anchoring device for an ALV cannula system in this study is meant 
to eliminate the need for sewing rings and coring of the heart.  The coring of the heart 
will be eliminated through the use of the previously explained Seldinger technique and 
the sewing rings will be eliminated through the screw itself.  To determine feasibility of 
the proposed sutureless-anchoring device as an acceptable alternative to sewing rings 
three tests were performed.  The first test was a leak test that utilized pressurized hearts 
with the cannula system implanted into the apex to determine if there was any leakage at 
the cannula-tissue interface.  The second test was a tensile pull test that determined the 
failure force of the cannula prototypes compared to LVAD-specific sewing rings.  The 
third test was a quantitative evaluation of the prototypes by cardiothoracic surgeons.  
They administered the prototypes to a heart and provided feedback about the feasibility 
of implantation and ease of use as compared to a sewing ring.  
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II. INSTRUMENTATION AND EQUIPMENT 
 
A. Fabrication of Device 
The sutureless anchoring device prototypes were fabricated using stainless steel 
conical springs (McMaster-Carr).  Springs were selected so that there was variation in 
length, large end outer diameter, and wire diameter (FIGURE 3).  .  
 
FIGURE 3: 1) Large end outer diameter, 2) Length, 3) Wire diameter 
 Spring dimensions of length, large-end diameter, and small-end diameter satisfied the 
anatomical (LV wall thickness) and device constraints (cannula outer diameter), as 
described above (Table II).  One side effect of aortic stenosis is left ventricular 
hypertrophy [7].  Because of this, a longer spring can be used, however, in this study no 
springs were used that were longer than 1 ¼”.  Preliminary tests using a Rapala 50 lb 
capacity spring scale showed that as wire diameter increased so too did the amount of 
force required to remove the spring from tissue (Table I).  
 
1 
2 
3 
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TABLE I 
PRELIMINARY PULL TEST RESULTS USING SPRING SCALE 
Spring 
Number 
Wire 
Diameter 
Failure Force 
(lbs.) 
Observations 
1 .038” 8 
Irreversible 
Deformation occurred 
2 .040” N/A* 
Up to 10lbs of force 
applied , did not pull 
out 
3 .042” N/A* 
Up to 10lbs of force 
applied , did not pull 
out 
4 .049” 13 
Began to pull out of 
tissue  
5 .055” 17 
Began to rip tissue at 
insertion point 
                      *Did not measure failure force due to lack of sound tissue remaining 
The large end outer diameters were determined to be larger than the outer diameter of the 
material being used to mimic the cannula.  Depending on the thickness of the spring, 
diagonal cutters or a Dremel with metal cutting circular saw attachment and a hand file 
were used to prepare the spring.  Half inch outer diameter hollow PVC tubing was used 
to mimic the 14mm diameter cannula.  
B. Preparation for Leak Testing 
        The following items were used for leak testing: scalpel, Foley Catheter with 
irrigation port, forceps, several hemostats, Curved Mayo surgical scissors, tray, bulb 
suction syringe, 10ml syringe, cup of water, hearts, and Smart Manometer M2series 
pressure manometer.    All hearts in this study were porcine hearts that were donated for 
educational purposes from either Boone’s Butcher Shop (Bardstown, KY), or JBS Swift 
& Co. (Louisville, KY).  
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C. Preparation for Tensile Testing 
The following items were used for tensile pull testing: two ¾” S hooks, one 1” S 
hook, a 6”x6”x4” (LxWxD) square electrical conduit box with a 2” diameter circular hole 
in the lid and accompanying screws, square plastic container fitted to the conduit, hearts, 
surgical gloves, biohazard bags, sanitation equipment, a Phillips head screwdriver, and a 
scalpel.  This test was performed to determine the failure force required to remove the 
cannula apparatus from the heart.  This study used an INSTRON model 4505 for tensile 
testing.  The equipment was located in the Department of Mechanical Engineering 
Testing Laboratory at the University of Louisville.  An electrical conduit box was used in 
place of the INSTRON base to accommodate the pig hearts (FIGURE 4).     
FIGURE 4- Electrical box on INSTRON base (left) and bolts securing box (right) 
After the conduit box was secured to the INSTRON base, the 1” S hook was placed in the 
upper grips (FIGURE 5).  
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FIGURE 5- 1” S hook secured in upper grips of INSTRON 
The INSTRON was programmed to run the samples at a tensile rate of 12mm/minute.  
This rate was held constant because variations in the rate could lead to differences in the 
results between trials.     
 The results of the tensile test on each cannula were compared to a control using 
four sewing rings, two Heartmate II and two HVAD (FIGURE 6).  Each ring was sewn to 
a separate heart by an experienced cardiothoracic surgeon using 2-0 Microfilament 
sutures and pledgets.  For this study eight pledgets and sutures were used for each sewing 
ringThe attached sewing rings were connected to the Instron setup using the same method 
and materials as described for the cannula prototypes.   
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FIGURE 6- Left: Two Heartmate II sewing rings. RIGHT: Two HVAD sewing rings. 
D. Preparation for Quantitative Feasibility of Implantation Survey 
        Prior to the survey of cardiothoracic surgeons the following items were obtained: 
porcine hearts, scalpel, surgical gloves, and copies of the survey form found in 
APPENDIX I.  Hearts were prepared for the surgeons using a scalpel to cut a hole in the 
apex of the heart that was no larger than a dime (FIGURE 7).  
 
FIGURE 7- Hole cut into apex of heart for cannula prototype implantation.  
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III. PROCEDURES 
 
A. Procedure for fabricating prototypes 
        Fabrication of the cannula prototypes was started by sharpening the tip of the spring 
on the large outer diameter end.  The springs used in this study required a portion of the 
tip to be removed; this was done on some springs with the diagonal cutters, and others 
using the Dremel with the metal cutting circular saw attachment.    Once the tip was 
removed, the newly exposed face was sharpened to mimic the tip of a cutting suture 
needle (FIGURE 8) using a hand file.  This was done by sharpening each side so they 
formed a triangle with the top portion of the spring being flat.   
 
 
FIGURE 8- Example of a cutting suture needle tip 
The spring was also sharpened so there was a slight upwards angle on the tip to facilitate 
initial penetration of the tissue.  A sharpened spring can be seen in FIGURE 9 below. 
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FIGURE 9- Sharpened spring and noticeable upwards angle 
 Sharpened springs were attached to 6-inch lengths of PVC tube to model the ALV 
cannula tip.  Using the Dremel and 1/20” drillbit, a hole was drilled into the tubing 
approximately 1.5” from one end of the tubing.  The spring was then trimmed on the 
small outer diameter end until it was able to slip over the outside portion of the tubing.  
After it was trimmed, it was positioned on the tubing so that the sharp tip was facing the 
short end of the tubing and the trimmed small outer diameter end of the spring was 
positioned in the hole.  Using the hand file, the short end of the tubing was rounded off so 
there were no sharp edges to affect the tissue during insertion.  This study utilized five 
separate springs with varying length, wire diameter, and large end outer diameter (Table 
II).   The number corresponding to each spring in the table will be how the springs are 
referred to through the rest of the paper.  As stated earlier, no spring should exceed 1 ¼” 
in length.  In addition, no spring was used that was shorter than 3/4” in length to ensure 
deep implantation into the cardiac tissue.  As stated earlier, in preliminary studies it was 
found that as wire diameter increased so too did the failure force (Table I).  Because of 
this, no springs were used with a smaller wire diameter than .045” while no springs were 
used that had a larger wire diameter than .055” due to limitations from McMaster-Carr.  
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Large end outer diameter was either .975” or .85” because those measurements allow 
clearance around the cannula prototype; however, it was not too large to inhibit the tissue 
from compressing to the cannula.  Larger outer diameters could be used but for simplicity 
only these two values were used in hopes that they would give a better understanding of 
how large end outer diameter affects test results.  
TABLE II 
LIST OF SPRINGS AND DIMENSIONS USED FOR THIS STUDY 
Spring 
Number 
Length 
(in.) 
Large Outer Diameter 
(in.) 
Small Outer Diameter 
(in.) 
Wire Diameter 
(in.) 
1 1 0.975 0.5 0.055 
2 1 0.85 0.281 0.055 
3 1.25 0.975 0.5 0.049 
4 0.75 0.85 0.438 0.049 
5 0.75 0.85 0.5 0.045 
 
 
B. Procedure for Performing Leak Testing 
         Leak testing was completed during this study to ensure the spring was able to 
form a seal at the tissue-cannula interface at high pressures similar to those experienced 
in patients with aortic stenosis.     
The cannula prototypes (Table II) were obtained and the tubing was filled with 
plumbers epoxy.  The epoxy was administered so that it covered any openings in the 
prototype so there was no leakage due to prototype fabrication during the testing.  Each 
heart had to be tested prior to ALV cannula insertion to ensure it could be pressurized.  
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To pressurize the heart, the aorta was clamped off with a large hemostat to block flow 
from the left ventricle. Once the aorta was clamped, the foley catheter was passed 
through the mitral valve into the left ventricle.  The 10ml syringe was filled with water 
and placed onto the luer lock port on the foley.  The syringe was used to fill the balloon 
on the end of the foley, and then removed so the balloon remained inflated.  It was 
determined that the balloon was occluding the mitral valve by pulling back on the foley. 
The bulb suction syringe was filled with water and placed in the middle port of the foley, 
pressure was then applied to the bulb.  The heart was analyzed as pressure was being 
applied for any leaks.  If there were any leaks the heart was deemed inappropriate for this 
study because it was unable to be pressurized. However, if the heart was capable of being 
pressurized then the bulb suction syringe was removed, the balloon was deflated by 
administering the syringe to the leur lock, and the foley was removed from the LV.  The 
scalpel was then used to administer a small circular incision, no bigger than a dime 
(FIGURE 6), through the apex and forceps were used to remove the tissue.  The first 
prototype was inserted into the incision up to the tip of the spring; once the spring came 
in contact with the tissue, it was turned clockwise until the spring was fully embedded in 
the tissue.  By placing the small finger through the mitral valve, we ensured the spring 
did not penetrate into the left ventricle on all hearts.  Once in place, the foley catheter was 
reinserted through the mitral valve and the balloon was filled using the 10ml syringe.  It 
was again ensured that the balloon was occluding the mitral valve, and then the 
monometer was placed on the third port of the foley catheter (FIGURE 10).   
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FIGURE 10- Foley Catheter port set up 1) 10mL syringe for inflating balloon on foley 2) 
Bulb suction syringe for applying pressure 3) Monometer for measuring pressure in the 
LV 
The monometer was zeroed.  The bulb suction syringe was filled with water.  It 
was then placed on the foley catheter and pressure was applied to the bulb until a 
maximum pressure was achieved.  The maximum pressure was then recorded.  Slight 
mitral regurgitation consistently occurred due to the lack of a tight seal between the 
mitral valve and the balloon on the foley catheter, however, the rate of LV pressurization 
was much greater than the regurgitation so it was assumed that the results were 
unaffected.  As a result of of the regurgitation, it was difficult to increase the pressure in 
gradual increments; therefore pressure was applied until the maximum pressure was 
achieved or until a leak occurred from the heart or prototype.  
This process was repeated on the same cannula an additional two times.  Once 
testing was completed on one cannula prototype the heart was disposed of and the test 
was repeated with a new heart and cannula prototype. 
1 
 
2 
 
3 
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FIGURE 11- Leak testing set up: 1) Cannula prototype 2) Foley Catheter occluding 
mitral valve 3)hemostat clamping off aorta 4) pressure being applied to ball suction 
syringe   
 The roles of each person during this procedure were as follows.  One person was 
used to monitor the monometer for the maximum pressure and to make sure there was no 
backflow of water into the manometer.  This person was responsible for recording the 
maximum pressure.  Another person was in charge of holding the foley catheter in place 
against the mitral valve because, due to high pressures in the left ventricle and the 
elasticity of the balloon, the foley catheter could be easily displaced without constant 
tension.  The third person was responsible for applying pressure to the bulb suction 
syringe and monitoring the heart for any leaks from the cannula or the heart itself.   
 
C. Procedure for tensile testing 
        Using a Dremel with a 1/8” drill bit, the PVC tubing of all the cannula prototypes 
had two holes drilled parallel from each other, ½” from the distal end of the tube.  The 
holes were drilled large enough so that the ¾” S hooks would fit easily into them.  
Cannula were ready for tensile testing once the holes were drilled into the tubing.  Using 
1
. 
 
2 
 
3 
 
4 
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the scalpel a small circular incision, no larger than a dime (FIGURE 7), was made in the 
first heart for testing. The prototype was implanted through the hole until the tip of the 
spring came into contact with the tissue; it was then rotated clockwise until the spring 
was fully embedded into the tissue.  The heart was then placed in the plastic container 
and the container was positioned in the conduit box secured to the Instron base.  The 
cannula was fed through the 2” opening in the lid, which was then secured to contain the 
heart.  The two ¾” S hooks were inserted into the two distal holes on the tubing and 
hooked onto the 1” S hook (FIGURE 12) by moving the INSTRON base upwards with 
the controller.  
 
FIGURE 12- Tensile pull testing set up 
The INSTRON base was moved down until the portion of the heart with the spring 
implanted in it began to pass through the hole in the lid (FIGURE 12).  This yielded a 
preload of 5-10N.  The cannula was monitored for any irregularities in the tissue as force 
was applied. The run was complete once the spring was fully removed from the tissue.  
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This procedure was performed three times per cannula prototype, with a new heart being 
used for each run.  
 To understand the results a control needed to be established.  This was completed 
by comparing results from the prototype tensile testing to tensile tests performed on 
sewing rings.  A heart with sewing ring sutured to it was obtained and the two ¾” S 
hooks were hooked underneath the sewing ring-tissue barrier (FIGURE 13).  The 
INSTRON platform was raised until the two ¾” S could hook into the 1” S hook.  The 
platform was the lowered until the sewing ring had passed through the lid of the box. The 
sewing ring was monitored for any irregularities in the tissue as force was gradually 
applied.  The program was run until the sewing ring was fully removed from the tissue. 
This procedure was performed for HeartWare HVAD sewing rings (n=2) and Thoratec 
HeartMate II sewing rings (n=2). The data from each trial was then exported for analysis.    
 
FIGURE 13- Left: ¾” S hooks hooked under the Heartmate II sewing ring.  Right: 2 ¾” S 
hooks hooked under HVAD sewing ring and into the 1” S hook in INSTRON grips. 
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D. Procedure for Quantitative Feasibility of Implantation Survey 
        Meetings were scheduled with two cardiothoracic surgeons.  Prior to their arrival, all 
hearts, which had circular incisions, were placed on a tray.  Cannula prototype 1 was 
given to the surgeons.  The device, its purpose, and brief implantation instructions were 
then described to surgeons so they understood their purpose in the study and had a basic 
understanding of how to perform the cannula insertion.  They were then instructed to 
implant the prototype into the heart.  After they had implanted the cannula they were 
administered the survey which can be found in APPENDIX I.  Surgeons were able to 
remain anonymous for this study.  After they had taken the survey their results were 
analyzed.  
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IV. RESULTS AND DISCUSSION  
A. Results and Discussion of Leak Test 
        The results for leak testing can be found in Table III below.  This test was a pass/fail 
test with passing being considered a test that did not leak at the cannula-tissue interface.  
A fail is considered any run that produced a leak at the cannula-tissue interface.  The goal 
of this test was to achieve pressure values above 150 mmHg, simulating the high 
pressures experienced in a patient with aortic stenosis [1].  Accordingly, trials that did not 
reach 150 mmHg due to non-device failures were not considered to be adequate tests of 
device function. 
TABLE III 
RESULTS FROM LEAK TESTING 
Spring 
Number 
Pressure (mmHg) 
Standard 
Deviation 
Result Observations Trial 
1 
Trial 
2 
Trial 
3 
Average 
1 173.0 180.9 131.4 177.0* 5.6* Pass Septum burst during trial 3 
2 195.0 192.6 110.7 193.8* 1.7* Pass Coronary artery leak during trial 3 
3 192.1 174.3 173.1 179.8 10.6 Pass   
4 185.7 181.8 158.6 175.4 14.7 Pass   
5 157.6 157.7 156.1 157.1 0.9 Pass   
*Average and standard deviation excludes trial that contained non-device related failure 
The results demonstrated in Table III show that all of the samples passed the 
testing meaning there were no leaks at the cannula-tissue interface.  The pressures at each 
trial represent the maximum achievable pressure during that trial.  The second criteria of 
the test was to reach pressures of greater than 150 mmHg, which was achieved in all but 
two runs.  The maximum pressure for Spring #1, Pressure 3 was 131.4 mmHg, which is 
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nearly 50 mmHg less than the maximum of either of the first two pressures, 180.9 
mmHg.  However, during the third pressure test the septum burst producing a leak and 
inhibiting the pressure from rising above the maximum.   The pressure was unable to 
continue rising because the right half of the heart was not a closed system.  The 
maximum pressure for spring 2 pressure 3 was 110.7, nearly 85 mmHg lower than the 
maximum of either of the first two pressures, 195.0 mmHg.  The cause of the lower value 
was due to the coronary arteries developing a leak, producing a stream of water from the 
heart.  This prevented the pressure from rising any higher than the maximum of this run.  
In these two cases, the first two pressures were high and fairly consistent.  It can be 
assumed that the pressure build up inside of the left ventricle during the first two runs 
lead to the malfunctions in the third run.  The weakening, potentially due to the tissue of 
the LV expanding, of the heart tissue over the course of the three pressures can be seen 
with the results from springs 2, 3, and 4, where the maximum pressure decreased with 
each sample.  Springs 1 and 5 had a slight increase in maximum pressure from the first 
run to the second, and then had a decreased pressure for the third run.  
TABLE IV 
AVERAGE PRESSURE FROM LEAK TESTING BY WIRE DIAMETER 
Wire 
Diameter 
Average 
Pressure 
Standard 
Deviation 
0.055 185.38 10.30 
0.049 183.48 7.45 
0.045 157.65 0.07 
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The values in this table were derived by taking the average of the results from 
each trial by grouping springs together based on their wire diameter.  However the third 
trial for each cannula was not taken into account in Table IV because of the non-device 
related failure during trial 3 for cannulas 1 and 2.  Springs 1 and 2 were used for the .055 
wire diameter, springs 3 and 4 were used for the .049 wire diameter, and spring 5 was 
used for the .045 wire diameter. As can be seen in Table IV, the average pressure 
decreased as wire diameter decreased, with a much greater decrease occurring between 
.049” and .045” than between .055” and .049”.  The wire diameter of .045 had an n-value 
of 1, while the other two wire diameters had an n-value of 2, which may be the reason for 
the larger decrease from .049” to .045”.   
Limitations that may hinder the results of this test method is the use of the same 
heart and incision for all three tests. With the same heart being exposed to high pressures 
multiple times the tissue may lose integrity and alter the final results.  This can be seen 
with the two trials where the heart failed due to leaks at the septum and coronary arteries. 
Variability in tissue from using a new heart per trial is also limited when using one heart 
for all three trials. These limitations could be taken into account by using a new heart for 
each trial.  However, a limitation to using a new heart with each trial during this testing 
was the integrity of the hearts that were obtained.  Most of the hearts obtained were not 
suitable for this procedure due to cuts made at the butcher shop.  If enough suitable hearts 
were obtained this test should be run on multiple hearts in triplicate, rather than a single 
heart in triplicate.   
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B. Results and Discussion of Tensile Test 
The tensile pull test was performed as a pass-fail test, however, the criteria was based 
on a control in this study.  The purpose of this device is to create a sutureless-anchoring 
mechanism therefore eliminating sewing rings from the implantation of the cannula.  To 
prove that the device is capable of anchoring the cannula in the tissue at similar forces to 
sewing ring, four sewing rings were tested.  The results of the sewing ring tests can be 
seen in Table VI and in FIGURE 17.  The maximum force recorded during the three 
tensile tests for each cannula can be found in Table V below.  The graphs showing the 
force over displacement for all three runs of each cannula prototype can be found in 
FIGURE 14 below.      
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FIGURE 14- Graphs of the results from tensile pull testing for cannula prototypes 
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TABLE V 
RESULTS FROM TENSILE TESTING 
Cannula 
Maximum Force (N) Average 
Force 
(N) 
Standard 
Deviation 
Trial 1 Trial 2 Trial 3 
1 43.84 67.05 34.4 48.43 16.8 
2 39.83 32.69 33.18 35.23 3.99 
3 42.78 37.05 28.69 36.17 7.09 
4 17.70 15.38 14.73 15.94 1.56 
5 26.12 14.00 8.38 16.17 9.07 
  
 Looking at Table V, some interesting observations should be noted.  The first 
observation is the maximum overall force for all tests and cannula is 67.05 N, which is 
more than 20 N larger than the next highest value, 43.84 N.  Cannula 1 returned the 
highest average force of 48.43 N, and cannula 4 delivered the lowest average force of 
15.94 N.  In four of the five cannula, the lowest of the maximum forces occurred during 
the final run.  This may be due to small amounts of deformation or fatigue to the spring, 
although no physical deformations were noticed.  The variance in maximum forces in 
each run may also be attributed to a new heart being used, and the differences in tissue 
thickness.  The hearts used had been refrigerated for eighteen hours prior to testing, 
which would decrease the elasticity of the tissue, and may have affected the results.  
However, heart storage and preparation was consistent for cannula prototypes and sewing 
rings, therefore potential changes in heart elasticity should not bias comparative analysis.  
Future studies with more specified spring dimensions will benefit by improved study 
design with more runs per prototype with fresh hearts per run. 
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 Based on the results of tensile testing, the maximum force seems to be affected by a 
combination of wire diameter and the size of the large end outer diameter.  This 
observation is based on viewing the the results from cannula 1, 2, and 3, in table VI 
below.  As can be seen, the average maximum force for cannula 1 is larger than that for 
cannula 2.  The only difference in the springs used for these two cannula is the large end 
of the springs outer diameter with the larger of the two being cannula 1.  Also, cannula 3 
has a larger maximum average force than cannula 2.  The differences in the springs used 
are length, wire diameter, and large end outer diameter.  To test this hypothesis the data 
was input into Minitab 16 and run using best subsets and a general regression.  The 
results from the best subsets test are in FIGURES 15 & 16 below.  Based on the best 
subsets results the best model for the current data is the model that only includes wire 
diameter and large outer diameter as the response variables.  The R-Sq value of 94.9 in 
combination with a low Mallows Cp (2.1) and S-value (4.5054) show this is a good 
model to use.  The data was then run through a general regression yielding p-values of 
0.072 for larger outer diameter and 0.066 for wire diameter.  These p-values are larger 
than 0.05, meaning that the variables are insignificant in this model, proving the 
hypothesis wrong.  With an expanded data set and the p-values in this model being near 
the goal of 0.05, it can be expected that in future testing these variables would become 
significant.    
 Another interesting observation from the data is that the springs with longer lengths 
(>0.75”) achieved a larger average failure force than those with shorter lengths (=0.75”).  
This is beneficial in this study because, as stated earlier, patients with left ventricular 
hypertrophy, as experienced in heart failure and AS, have larger wall thickness at the 
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apex.  Therefore a longer spring can be used which would allow for deeper embedding 
into this tissue providing extra securement while in a higher pressure environment.   
 
FIGURE 15- Best subsets analysis of Average Force (N) vs. Large outer diameter, Wire 
diameter, and length. 
 
27 
 
 
FIGURE 16- Regression analysis results of Average force vs. large outer diameter and 
wire diameter 
 To be able to prove that the design proposition of this study is a suitable 
replacement for current technology, sewing rings, a control had to be tested.  The sewing 
ring tests were performed under the same conditions as the cannula prototype.  The 
results for the four sewing rings that were tested can be found in Table VII. 
 
FIGURE 17: Graphs of Tensile pull test data for sewing rings 
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TABLE VI 
MAXIMUM AND AVERAGE FORCES FOR SEWING RING TENSILE TESTS 
 
Maximum Force (N) Average 
Maximum 
Force (N) 
Standard 
Deviation 
 
Sewing Ring 
1 
Sewing Ring 
2 
HVAD 89.79 86.08 87.94 2.62 
Heartmate II 73.64 109.74 91.69 25.53 
 
The results from the HVAD sewing rings were consistent with each other, while the 
Heartmate II sewing rings had a higher degree of variability.  The average maximum 
force between the two brands only varied by 3.75 N so one brand doesn’t seem to be 
more suitable than the other.  However, the maximum and minimum forces from all the 
tests were achieved during the tests of Heartmate II sewing rings with a minimum force 
of 73.636 N and maximum force of 109.735 N.   
 When comparing the results from the cannula prototypes and the control, Table 
VIII, it can be seen that the sewing rings were able to achieve greater maximum forces 
than the cannula prototypes.  One point of interest is the maximum force of Cannula 1, 
67.05 N, and the Run 1 Maximum Force for the Heartmate II sewing ring, 73.64 N, a 
difference of 6.59N.  This difference in sample forces shows that the Cannula 1 prototype 
is nearly capable of achieving the same maximum force in a run as a sewing ring.  
However, the average force difference between the cannula 1 prototype and the 
Heartmate II sewing rings is 43.26 N.  This could be attributed to the fact that the sewing 
rings (n=4) were each tested once on different hearts, while each cannula prototype was 
29 
 
tested three times on the same heart.  Deformation may have occurred during the cannula 
prototype tests that lead to smaller maximum forces in later tests.   
 The differences in forces may also be attributed to the natural variances in hearts.  
Each test utilized a new heart which leads to variances outside of our control.  One heart 
may have had a thick myocardium that allowed deep implantation of the cannula 
prototype, while others may have had a thin myocardium that the cannula penetrated 
through.  If the thickness of the myocardium were measured during each test this could 
be determined as a significant factor, and may be something to record in future testing.  
Increasing the sample size in future tests will allow for a larger data set.  Having 
duplicates of the same prototype to test will also determine if deformation is a factor in 
the tests.  Each duplicate cannula should be tested multiple times and the results 
compared to determine if there is any consistency in results over the course of multiple 
trials, proving that deformation occurred.   
 Another point of variance amongst the prototypes is the circular incision made to the 
apex.  The incision was made using a scalpel, so there was variance from one incision to 
the next.  If the incision was too small tissue may have been damaged upon insertion of 
the prototype.  On the contrary, if the incision was too large, the tissue may not have 
compressed to the prototype as well. Instead of using a scalpel, in future testing a dilator 
kit should be obtained that would allow for implantation using the Seldinger technique.    
The data obtained would be best suited to the procedure of implantation in the body. 
When the sewing rings were implanted in the tissue, the tissue in the center was not 
cored.  This should not make a difference in the results of the tensile testing, however, 
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future testing should core out the tissue.  The extra tissue may have increased the 
integrity of the sewing ring leading to larger failure forces.     
TABLE VII 
RESULTS FROM ALL TENSILE TESTS 
Device 
Run 1 
Maximum 
Force (N) 
Run 2 
Maximum 
Force (N) 
Run 3 
Maximum 
Force (N) 
Average 
Force 
(N) 
Standard 
Deviation 
Maximum 
Force (N) 
Cannula 1 43.84 67.05 34.4 48.43 16.80 67.05 
Cannula 2 39.83 32.69 33.18 35.23 3.99 39.83 
Cannula 3 42.78 37.05 28.69 36.17 7.09 32.43 
Cannula4 17.7 15.38 14.73 15.94 1.56 17.7 
Cannula5 26.12 14 8.38 16.17 9.07 26.12 
HVAD Sewing Ring 89.79 86.08   87.94 2.62 89.79 
Heartmate II Sewing Ring 73.64 109.74   91.69 25.53 109.74 
 
Interesting observations to make about the graphs in FIGURE 13 is that in most 
tests there is a maximum peak followed by a drop in force, followed by an increase in 
force.  Sometimes this trend occurs more than once.  This was the result of one portion of 
the spring being pulled from the tissue.  As the spring was pulled from the tissue, it came 
out in layers because of the turns.  After one portion would rip out of the tissue the rest of 
the spring embedded in the tissue would remain secured in the tissue until the next 
portion of the spring would tear from the tissue.  If deformation were to occur, it is 
hypothesized that, this is the point in which it would.  For instance, if a large force was 
achieved after the first portion of the spring was removed from the tissue, while the rest 
of the spring remained secure, deformation may occur at this point.   With each spring 
being used in multiple tests the chances of deformation occurring increased significantly 
versus if a spring was used only once.   
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The only time the cannula would experience tensile forces, similar to this test, in 
the body would be if the surgeon were to apply force after implanting the cannula to 
ensure proper placement.  The only other forces the cannula should come in contact with 
are the compressive and tensile forces on the cannula from the heart beating and if there 
is any weight associated with the graft as it fills with blood.  These forces are not 
expected to overcome the forces the cannula would experience in this tensile testing. 
This study did not take into account a long term analysis of the cannula prototypes 
and their interactions with the tissue.  This device is intended for implantation in the heart 
so fatigue could become an issue as the number of heartbeats experienced increases over 
time.  This should be simulated using a method that mechanically reproduces the cyclic 
nature of the beating heart.   
C. Results and Discussion of the Quantitative Feasibility of Implantation Survey 
The completed survey forms for the quantitative survey of device can be found in 
APPENDIX I.  Table VIII shows the results per each question.  One of the survey 
participants thought the spring was very easy to initially penetrate the tissue, was very 
easy to fully implant in the tissue, was less difficult to administer than a suture ring, 
but would still like to include suturing with the device.  The other survey participant 
varied from the first participant by thinking that the spring wasn’t very difficult or 
easy to initially penetrate the tissue, but was in the middle, and that they thought the 
device was only easy, not very easy, to fully implant in the tissue.  Some comments 
that were received are as follows, “Little hard to start, but moves easily through the 
myocardium.  However, it may be a little too easy to some degree.”  The results 
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from the survey validated the design goals that the device would be easier and quicker 
to implant than a sewing ring.  However, at the current stage of development a 
mentality persists that a sewing ring is a better solution.  This survey should be 
administered to more CT surgeons in the future to continue to expand the results from 
Table VIII.  The need for an additional sewing ring to be included with the cannula 
may be due to the crudeness of this initial prototype.  As the study progresses, and 
specific dimensions are determined for the spring, a final prototype should be 
fabricated using pyrolytic carbon (PYC) as the cannula material with the screw 
embedded in the PC.  The survey should then be administered to the CT surgeons 
again to determine if their decision on needing a sewing ring has changed.  Even still, 
only in vivo pre-clinical testing will determine if redundant attachment systems are 
necessary. 
TABLE VIII. 
RESULTS OF QUANTITATIVE SURVEY OF DEVICE 
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V. CONCLUSIONS 
 Based on the results from the leak testing it can be concluded that all cannula 
prototypes are capable of maintaining a leak proof seal at the cannula-tissue interface 
during high pressures similar to those experienced during severe aortic stenosis.  The 
results of the tensile pull testing show that none of the cannula prototypes are capable of 
achieving failure forces of sewing rings.  The cannula that was able to achieve the highest 
forces was Cannula prototype 1 which, in conjunction with leak test results, can be called 
the best overall performing prototype.  This prototype had a large wire diameter and a 
large open end wire diameter.  The results of the quantitative survey of the device showed 
that the device was less difficult to administer than a sewing ring, but the participants 
would still like to include sutures during a procedure as a precaution.  It can be concluded 
that there is promise for the device to be successful in the future, but the tests need to be 
expanded to include springs with larger outer diameters and wire diameters, and in vivo 
studies should be performed to determine efficacy.  
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VI. RECOMMENDATIONS 
 While none of the prototypes were capable of achieving failure forces that were 
better than the forces achieved by the sewing rings, the second run of the first cannula did 
produce a result similar to that of the Heartmate II sewing ring.  One hypothesis for why 
the failure force results for all the cannula prototypes decreased over time is that there 
was deformation that occurred.  To test this hypothesis three Cannula 1 prototypes should 
be made.  Each of these cannula should be tested at least three times and then the results 
compared.  This will allow the tester to see if the cannula is capable of achieving higher 
forces, but also to see if the failure force decreases gradually during each test, proving 
that there is deformation occurring.  Additional tests should be run on the sewing rings to 
ensure accurate data, especially on the Heartmate II sewing ring which had a range of 
36.1 N in the two tests.  Additional tests would help pinpoint a more accurate average 
failure force.   
 Based on the results of the tensile tests a rough hypothesis was formulated 
suggesting that larger wire diameters in conjunction with larger open end outer diameters 
lead to higher failure forces, however this was not supported by statistical analysis at this 
low sample-size.  However, it can be expanded for future tests by testing springs with 
larger wire diameter and open end outer diameter combinations to determine whether any 
of the factors are significant with a larger data set.  The spring selection from McMaster-
Carr is limited so another conical spring provider should be found, however, ordering 
custom springs also serves as a viable option.  The length will remain constant in future 
testing (1”) because this provides adequate securement based upon our results.  It would 
not be detrimental to vary the spring length in future studies, once the appropriate wire 
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diameter and large outer diameter combination has been found, to further determine the 
effects of length on test results.  If this path is pursued the anatomical limitations 
previously stated would still need to be taken into account so the spring does not 
penetrate the left ventricle. While this study may not have been able to prove that any of 
the springs used are capable of removing the need for sewing rings during apical cannula 
implantation, it did provide valuable results for future studies.  The processes used in this 
study have room for improvement, with fabricating multiple prototypes for springs with 
the same dimensions.  There is promise for this method to become the surgical 
implantation method of the future, but more testing needs to be conducted to prove that 
one spring is consistently able to provide a leak proof tissue-cannula interface, higher 
tensile forces than sewing rings, and positive reviews from CT surgeons.   
 The springs recommended for future testing can be found in table IX.  These 
springs have a constant length of 1”, but has varying wire diameter (.055-.060”) and large 
end outer diameter (.975-1.25”).  The results from these springs combined with the 
results from the springs in this paper should be combined and analyzed statistically to 
determine significance of factors.  Duplicates of each spring should be obtained to make 
multiple prototypes of each number.  This will allow for a larger data set to be obtained 
during tensile testing, if each prototype is tested multiple times.  
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TABLE IX 
RECOMMENDED SPRINGS FOR FUTURE TESTING 
Spring 
Number 
Spring Dimensions (in.) 
Length  
Wire 
Diameter 
Large end 
outer 
diameter 
1 1.00 0.055 1.15 
2 1.00 0.055 1.25 
3 1.00 0.060 0.975 
4 1.00 0.060 1.15 
5 1.00 0.060 1.25 
  
 Cannulation of the LV apex for AVB and VAD implantation can be time 
consuming and lead to bleeding complications or inflow occlusion. The goal of this 
project was to develop a sutureless-anchoring device for an apical left ventricular (ALV) 
cannula system.  Through leak testing, tensile pull testing, and a quantitative assessment 
of the device by CT surgeons it was deemed that none of the springs tested in this study 
were capable of performing better in these tests than sewing rings.  However, there was 
one spring that was capable of achieving a tensile force similar to that of a sewing ring. 
The results of that test in conjunction with the results from leak testing and the feedback 
given from CT surgeons show that there is promise this design could potentially replace 
the need for apical coring and cannulation during AVB and VAD implantations.   
  
37 
 
 
 
 
 
 
 
 
 
 
LIST OF REFERENCES 
 
1. Chin, D. (2009). "Echocardiography for transcatheter aortic valve implantation." 
European Journal of Echocardiography 10(1): i21-i29. 
 
2. Bermejo J. The effects of hypertension on aortic valve 
stenosis. Heart. 2005;91:280–282. 
 
3. Slaughter, M. S., et al. (2010). "Clinical management of continuous-flow left 
ventricular assist devices in advanced heart failure." The Journal of heart and lung 
transplantation : the official publication of the International Society for Heart 
Transplantation 29(4): S1-S39. 
 
4. Abiomed. 2010. Impella LD with the Impella Console Circulatory Support 
System Instructions for use & Clinical Reference Manual.  
 
5. Losi, M. A., et al. (2010). "Echocardiography in patients with hypertrophic 
cardiomyopathy: usefulness of old and new techniques in the diagnosis and 
pathophysiological assessment." Cardiovasc Ultrasound 8: 7. 
 
6.  Reddy, M., et al. (2008). "Apical hypertrophic cardiomyopathy: potential utility 
of Strain imaging." Eur J Echocardiogr 9(4): 560-562. 
 
7. Chambers, J. (2006). "The left ventricle in aortic stenosis: evidence for the use of 
ACE inhibitors." Heart 92(3): 420-423. 
 
  
38 
 
 
 
 
 
 
 
 
 
 
APPENDIX I 
 
QUATITATIVE FEASIBILITY OF IMPLANTATION SURVEY AND  
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
On a scale of 1-5 with 1 being very difficult and 5 being very easy, how difficult was it to make 
initial penetration into the tissue? 
1   2   3   4  5 
Additional Comments:__________________________________________________________ 
 
On a scale of 1-5 with 1 being very difficult and 5 being very easy, how difficult was it to fully 
implant the screw into the tissue? 
1   2   3   4  5 
   
Additional Comments:___________________________________________________________ 
 
Would this be more difficult, less difficult, or the same to administer than a sewing ring? 
More Difficult   Less Difficult  The Same 
Additional Comments:____________________________________________________________ 
 
Would you trust this method by itself or would you still prefer to add suturing? 
Trust by itself   Prefer to include sutures   
 
Any other comments or advice you may have? 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
____________________________ 
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